Bayer seeks approval for its liver cancer drug
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
Pharmaceuticals, Biotechnology and Life Sciences
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
Amryt has received orphan drug designation from U.S. Food and Drug Administration (FDA) for its drug compound…
FDA granted accelerated approval to Lartruvo (olaratumab) injection, in combination with doxorubicin, for the treatment of adult patients…
Ajanta Pharma has gotten US FDA’s approval to launch its high blood pressure tablets Amlodipine
India’s Koanna gets marketing approval from MHRA for Imatinib tablets
Novartis gets FDA Priority Review for first-line treatment of HR+/HER2-advanced breast cancer
BD has gotten FDA market authorization for a first-of-its-kind molecular test…
Premaitha Health has gotten UK’s Department of Health approval to make non-invasive prenatal tests (“NIPT”)
Sanofi and Regeneron Pharmaceuticals have announced the FDA issued a Complete Response Letter (CRL) regarding…
Allergan has received approval from the FDA for Restasis, treatment to help patients with a type of Chronic Dry Eye …